Merck & Co., Inc. MRK
Set alert
144.68 USD -3.68 -2.48%
As of Nov 3, 1:05 PM ET
144.35 Day range 147.62
82.49 52-week range 156.45
- YTD
- +37.45%
- 1 year
- +75.39%
- Open
- 147.02
- Prev close
- 148.36
- Mkt cap
- 357.02B
- Vol
- 3.50M
- Avg vol
- 10.33M
- EPS
- 0.99
- P/E
- 146.17
- Div yield
- 2.32%
More statistics
- Low
- 144.35
- High
- 147.62
- Forward P/E
- 16.34
- Beta
- 0.12
- Short ratio
- 2.68
- Inst. own
- 82.88%
- Dividend
- 3.40
- Ex-div date
- Sep 14, 2026
- Earnings
- Feb 2, 2027
- 50-d avg
- 146.86
- 200-d avg
- 126.71
- 1y target
- 159.91
3M chart
Events in this range
- Aug 4, 2026Earnings: -0.13; estimate -0.27049; surprise 51.94%
- Sep 15, 2026Dividend: 0.85
- Oct 12, 2026Rating: Citigroup · Neutral → Neutral
- Oct 26, 2026Rating: Barclays · Overweight → Overweight
- Oct 29, 2026Earnings: 2.49; estimate 2.09; surprise 19.14%
- Oct 30, 2026Rating: Guggenheim · Buy → Buy
- Oct 30, 2026Rating: RBC Capital · Sector Perform → Sector Perform
- Oct 30, 2026Rating: JP Morgan · Overweight → Overweight
- Nov 2, 2026Rating: Cantor Fitzgerald · Neutral → Neutral
Signals (24)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Nov 3, 2026 | 3 hours ago |
| SMA: Bearish | Nov 3, 2026 | 3 hours ago |
| SMA: Bullish | Oct 30, 2026 | 4 days ago |
| MACD: Buy Signal | Oct 30, 2026 | 4 days ago |
| SMA: Bullish | Oct 29, 2026 | 5 days ago |
| MACD: Sell Signal | Oct 26, 2026 | 1 week ago |
| SMA: Bearish | Oct 23, 2026 | 1 week ago |
| SMA: Bearish | Oct 23, 2026 | 1 week ago |
| SMA: Bullish | Oct 20, 2026 | 2 weeks ago |
| SMA: Bullish | Oct 20, 2026 | 2 weeks ago |
| MACD: Buy Signal | Oct 20, 2026 | 2 weeks ago |
| SMA: Bearish | Oct 19, 2026 | 2 weeks ago |
| SMA: Bearish | Oct 19, 2026 | 2 weeks ago |
| SMA: Bullish | Oct 16, 2026 | 2 weeks ago |
| SMA: Bearish | Oct 15, 2026 | 2 weeks ago |
| SMA: Bullish | Oct 14, 2026 | 2 weeks ago |
| SMA: Bullish | Oct 14, 2026 | 2 weeks ago |
| SMA: Bearish | Oct 13, 2026 | 3 weeks ago |
| SMA: Bullish | Oct 9, 2026 | 3 weeks ago |
| SMA: Bearish | Oct 5, 2026 | 4 weeks ago |
Newest 20 of 24.
Analyst view
Consensus: buy
Buy
Price target (mean) 159.91 +10.5% upside
Now 144.68
- Target (low)
- 105.00
- Target (mean)
- 159.91
- Target (high)
- 186.00
Ratings (0m) 28 19 buy · 9 hold · 0 sell
- Strong buy5
- Buy14
- Hold9
- Sell0
- Strong sell0
Recommendation trend
- This month 28
- 1 month ago 27
- 2 months ago 28
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 1.79 | 1.71 – 1.96 | 2.04 | -12.1% | 16.37B | -0.2% | 18 |
| Next quarter | 2.17 | 2.04 – 2.30 | -1.28 | +269.5% | 16.48B | +1.2% | 8 |
| Current year | 2.76 | 2.50 – 2.99 | 8.98 | -69.3% | 67.19B | +3.4% | 25 |
| Next year | 9.08 | 8.50 – 9.77 | 2.76 | +229.6% | 69.58B | +3.6% | 23 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 2, 2026 | Cantor Fitzgerald | Maintained | Neutral | Neutral |
| Oct 30, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Oct 30, 2026 | RBC Capital | Maintained | Sector Perform | Sector Perform |
| Oct 30, 2026 | Guggenheim | Maintained | Buy | Buy |
| Oct 26, 2026 | Barclays | Maintained | Overweight | Overweight |
| Oct 12, 2026 | Citigroup | Maintained | Neutral | Neutral |
| Oct 12, 2026 | RBC Capital | Maintained | Sector Perform | Sector Perform |
| Oct 8, 2026 | Cantor Fitzgerald | Maintained | Neutral | Neutral |
| Oct 7, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Oct 5, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Sep 29, 2026 | Scotiabank | Maintained | Sector Outperform | Sector Outperform |
| Sep 10, 2026 | HSBC | Maintained | Buy | Buy |
| Sep 9, 2026 | Leerink Partners | Maintained | Outperform | Outperform |
| Sep 8, 2026 | Guggenheim | Maintained | Buy | Buy |
| Sep 4, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Aug 25, 2026 | Wolfe Research | Maintained | Outperform | Outperform |
| Aug 25, 2026 | Argus Research | Maintained | Buy | Buy |
| Aug 21, 2026 | Goldman Sachs | Maintained | Buy | Buy |
| Aug 20, 2026 | BMO Capital | Maintained | Outperform | Outperform |
| Aug 20, 2026 | UBS | Maintained | Buy | Buy |
| Aug 20, 2026 | RBC Capital | Downgrade | Outperform | Sector Perform |
| Aug 20, 2026 | Morgan Stanley | Upgrade | Equal-Weight | Overweight |
| Aug 12, 2026 | Daiwa Capital | Upgrade | Neutral | Outperform |
| Aug 11, 2026 | Argus Research | Maintained | Buy | Buy |
| Aug 5, 2026 | Guggenheim | Maintained | Buy | Buy |
| Jul 29, 2026 | Barclays | Maintained | Overweight | Overweight |
| Jul 13, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Jul 13, 2026 | BMO Capital | Maintained | Outperform | Outperform |
| Jul 13, 2026 | Guggenheim | Maintained | Buy | Buy |
| Jul 9, 2026 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |